Cannabinoid-Elicited Conditioned Place Preference in a Modified Behavioral Paradigm

Biological and Pharmaceutical Bulletin

Volumn 39, Issue 5, 2016, Pages 747-753

  Liu, Tao ^a   Zheng, Qiaohua ^a   Qian, Zhaoqiang ^a   Wang, Haoquan ^a   Liu, Zhiqiang ^a   Ren, Wei ^a   Zhang, Xia ^b   Han, Jing ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cannabinoid; Conditioned place preference (cpp); Drug reward

Indexed keywords

DEXANABINOL; DRONABINOL;

ADVERSE OUTCOME; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; MALE; NONHUMAN; PLACE PREFERENCE; PROCESS OPTIMIZATION; RAT; REWARD; SELECTION BIAS; ANALOGS AND DERIVATIVES; ANIMAL; CONDITIONING; DRUG EFFECTS; LONG EVANS RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DRONABINOL; MALE; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; REWARD;

EID: 84968648369     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b15-00834     Document Type: Article

References (27)

1. Volkow ND, Morales M. The brain on drugs: From reward to addiction. Cell, 162, 712-725 (2015).
2. Ginsburg BC, Lamb RJ. Reinforcement of an alternative behavior as a model of recovery and relapse in the rat. Behav. Processes, 94, 60-66 (2013).
3. Cheer JF, Kendall DA, Marsden CA. Cannabinoid receptors and reward in the rat: A conditioned place preference study. Psychopharmacology, 151, 25-30 (2000).
4. Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade. Addict. Biol., 12, 227-462 (2007).
5. Bali A, Randhawa PK, Jaggi AS. Stress and opioids: Role of opioids in modulating stress-related behavior and effect of stress on morphine conditioned place preference. Neurosci. Biobehav. Rev., 51, 138-150 (2015).
6. Lepore M, Vorel SR, Lowinson J, Gardner EL. Conditioned place preference induced by delta 9-tetrahydrocannabinol: Comparison with cocaine, morphine, and food reward. Life Sci., 56, 2073-2080 (1995).
7. ElSohly MA, Slade D. Chemical constituents of marijuana: The complex mixture of natural cannabinoids. Life Sci., 78, 539-548 (2005).
8. Valjent E, Maldonado R. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology, 147, 436-438 (2000).
9. Aguilar MA, Rodriguez-Arias M, Minarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res. Rev., 59, 253-277 (2009).
10. Maldonado R, Rodriguez de Fonseca F. Cannabinoid addiction: Behavioral models and neural correlates. J. Neurosci., 22, 3326-3331 (2002).
11. Panlilio LV, Justinova Z, Goldberg SR. Animal models of cannabinoid reward. Br. J. Pharmacol., 160, 499-510 (2010).
12. Han J, Kesner P, Metna-Laurent M, Duan T, Xu L, Georges F, Koehl M, Abrous DN, Mendizabal-Zubiaga J, Grandes P, Liu Q, Bai G, Wang W, Xiong L, Ren W, Marsicano G, Zhang X. Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal ltd. Cell, 148, 1039-1050 (2012).
13. Moreira FA, Aguiar DC, Guimaraes FS. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology, 52, 958-965 (2007).
14. Chen JH, Liang J, Wang GB, Han JS, Cui CL. Repeated 2 Hz peripheral electrical stimulations suppress morphine-induced CPP and improve spatial memory ability in rats. Exp. Neurol., 194, 550-556 (2005).
15. Sañudo-Peña MC, Tsou K, Delay ER, Hohman AG, Force M, Walker JM. Endogenous cannabinoids as an aversive or counterrewarding system in the rat. Neurosci. Lett., 223, 125-128 (1997).
16. Blázquez C, Chiarlone A, Bellocchio L, Resel E, Pruunsild P, García-Rincón D, Sendtner M, Timmusk T, Lutz B, Galve-Roperh I, Guzmán M. The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/AKT/mTORC1/BDNF pathway. Cell Death Differ., 22, 1618-1629 (2015).
17. Zheng Y, Reid P, Smith PF. Cannabinoid cb1 receptor agonists do not decrease, but may increase acoustic trauma-induced tinnitus in rats. Front. Neurol., 6, 60 (2015).
18. Lazenka MF, Selley DE, Sim-Selley LJ. Brain regional differences in cb1 receptor adaptation and regulation of transcription. Life Sci., 92, 446-452 (2013).
19. Isokawa M. Cellular signal mechanisms of reward-related plasticity in the hippocampus. Neural Plast., 2012, 945373 (2012).
20. Murphy NP, Lee Y, Maidment NT. Orphanin fq/nociceptin blocks acquisition of morphine place preference. Brain Res., 832, 168-170 (1999).
21. Dewey WL. Cannabinoid pharmacology. Pharmacol. Rev., 38, 151-178 (1986).
22. Vlachou S, Nomikos GG, Stephens DN, Panagis G. Lack of evidence for appetitive effects of delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents. Behav. Pharmacol., 18, 311-319 (2007).
23. Brielmaier JM, McDonald CG, Smith RF. Nicotine place preference in a biased conditioned place preference design. Pharmacol. Biochem. Behav., 89, 94-100 (2008).
24. García-Lecumberri C, Torres I, Martin S, Crespo JA, Miguens M, Nicanor C, Higuera-Matas A, Ambrosio E. Strain differences in the dose-response relationship for morphine self-administration and impulsive choice between lewis and fischer 344 rats. J. Psychopharmacol., 25, 783-791 (2011).
25. Gardner EL, Lowinson JH. Marijuana's interaction with brain reward systems: update 1991. Pharmacol. Biochem. Behav., 40, 571-580 (1991).
26. Hill MN, Froc DJ, Fox CJ, Gorzalka BB, Christie BR. Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo. Eur. J. Neurosci., 20, 859-863 (2004).
27. Murray JE, Bevins RA. Cannabinoid conditioned reward and aversion: Behavioral and neural processes. ACS Chem. Neurosci., 1, 265-278 (2010).